Vocal fold palsy following vinca alkaloid treatment

Journal of Laryngology and Otology

Volumn 112, Issue 5, 1998, Pages 485-487

  Burns, B V ^a,b   Shotton, J C ^a  

^a Kent County Ophthalmic and Aural Hospital   (United Kingdom)

^b Kent County Ophthalmic and Aural Hospital

Author keywords

Complications; Vinblastine; Vinca alkaloids; Vincristine; Vocal fold palsy

Indexed keywords

VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HODGKIN DISEASE; HUMAN; MALE; VOCAL CORD PARALYSIS;

EID: 0031817550     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1017/s002221510014085x     Document Type: Article

References (21)

1. Annino, D. J. Jr., MacArthur, C. J., Friedman, E. M. (1992) Vincristine induced recurrent laryngeal nerve paralysis. Laryngoscope 102(11): 1260-1262.
2. Bohannon, R. A., Miller, D. G., Diamond, H. D. (1963) Vincristine in the treatment of lymphomas and leukaemias. Cancer Research 23: 613-621.
3. Bradley, W. B., Lassman, L. P., Pearce, G. W., Walton, J. N. (1970) The neuromyopathy of vincristine in man: clinical, electrophysiological and pathological studies. Journal of Neurological Science 10: 107-131.
4. Brook, J., Schreiber, W. (1971) Vocal fold paralysis: a toxic reaction to vinblastine (NSC-49842) therapy. Cancer Chemotherapy Reports - Part 1. 55: 591-593.
5. Casey, E. B., Jellife, A. M., LeQuesne, P. M., Millet, Y. L. (1973) Vincristine neuropathy: clinical and electrophysiological changes. Brain 96: 69-86.
6. Chisholm, R. C., Curry, S. B. (1978) Vincristine induced dysphagia. Southern Medical Journal 71(11): 1364-1365.
7. Delaney, P. (1982) Vincristine-induced laryngeal nerve paralysis. Neurology 32(11): 1285-1288.
8. Donaghy, M. J. (1996) Vincristine and neuropathies. Prescriber's Journal 36(2): 116-169.
9. Holland, J. F., Scharlau, C., Gailani, S., Krant, M. J., Olson, K. B., Horton, J., Shnider, B. I., Lynch, J. J., Owens, A., Carbone, P. P., Colsky, J., Grob, D., Miller, S. P., Hall, T. C. (1973) Vincristine treatment of advanced cancer: a co-operative study of 392 cases. Cancer Research 33: 1258-1264.
10. Legha, S. S. (1986) Vincristine neurotoxicity. Pathophysiology and management. Medical Toxicology 1(6): 421-427.
11. Lugassy, G., Shapira, A. (1990) Sensorineural hearing loss associated with vincristine treatment. Blut 61(5): 320-321.
12. Mahajan, S. L., Ikeda, Y., Myers, T. J., Baldini, M. G. (1981) Acute acoustic nerve palsy associated with vincristine therapy. Cancer 47(10): 2404-2406.
13. McCarthy, G. M., Skillings, J. R. (1991) A prospective cohort study of the orofacial effects of vincristine neurotoxicity. Journal of Oral Pathology and Medicine 20(7): 345-349.
14. McCarthy, G. M., Skillings, J. R. (1992) Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surgery, Oral Medicine, Oral Pathology 74(3): 299-304.
15. Postma, T. J., Benard, B. A., Huijgens, P. C., Ossenkoppele, G. J., Heimans, J. J. (1993) Long-term effects of vincristine on the peripheral nervous system. Journal of Neuro-Oncology 15(1): 23-27.
16. Ripps, H., Carr, R. E., Siegel, I. M., Greenstein, V. C. (1984) Functional abnormalities in vincristine-induced night blindness. Investigative Ophthalmology and Visual Science 25(7): 787-794.
17. Rosenthal, S., Kaufman, S. (1974) Vincristine neurotoxicity. Annals of Internal Medicine 80: 333-373.
18. Teichmann, K. D., Dabbagh, N. (1988) Severe visual loss after a single dose of vincristine in a patient with spinal cord astrocytoma. Journal of Ocular Pharmacology 4(2): 117-121.
19. Tobias, J. D., Bozeman, P. M. (1991) Vincristine-induced recurrent laryngeal nerve paralysis in children. Intensive Care Medicine 17(5): 304-305.
20. Whittaker, J. A., Griffith, I. P. (1977) Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. British Medical Journal 1: 1251-1252.
21. Wisniewski, H., Shelanski, M. L., Terry, R. D. (1968) Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells. Journal of Cell Biology 38: 224-229.